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Hospital and community isolates of uropathogens at a 
tertiary hospital in South Africa
T M Habte, S Dube, N Ismail, A A Hoosen
Urinary tract infections (UTIs) are a major public health 
problem in terms of morbidity and financial cost, and incur 
the highest total health care cost among urological diseases, 
exceeding that of chronic renal failure even when dialysis 
and renal transplantation are included.1 The introduction 
of antimicrobial therapy has contributed significantly to the 
management of UTIs; however, the main problem with current 
antibiotic therapies is the rapid emergence of antimicrobial 
resistance in hospitals and the community.2
Routinely, urine culture and sensitivity is done to 
determine the cause of sepsis. Although the literature mostly 
profiles antimicrobial susceptibility in children, studies of 
uropathogens in adults show that in the last decade many 
urinary tract pathogens have become resistant to antimicrobial 
agents. This is of major public health importance, especially 
concerning Escherichia coli, a commonly isolated uropathogen, 
and other Enterobacteriaceae which have become less 
susceptible to widely used antibiotics such as ampicillin, 
amoxicillin, co-amoxiclav and co-trimoxazole.3 All institutions 
should therefore continue surveillance of uropathogens, since 
antibiotic resistance varies over time, and their antimicrobial 
profile also varies depending on the locality from which they 
were isolated.4
This retrospective study investigated the common 
uropathogens isolated from patients attending Dr George 
Mukhari (DGM) Hospital in Ga-Rankuwa, Pretoria, and 
surrounding referral clinics and hospitals. DGM is a teaching 
tertiary hospital about 30 km north-west of Pretoria. The 
susceptibility pattern of the uropathogens to different 
antimicrobial agents was analysed, and we compared the 
resistance pattern of the uropathogens isolated at DGM with 
those from its referral sites.
Materials and methods
We reviewed laboratory records of urine specimens submitted 
for investigations from patients admitted to various specialties at 
DGM and its referral clinics over a 1-year period (1 November 
2005 - 31 October 2006). Data collected included patients’ age 
and sex, location (hospital or clinic), significant urinary isolates 
and their antimicrobial susceptibility profile.
Routine processing of urine specimens at the laboratory 
includes microscopic examination for cell count and culture 
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Aim. To investigate the profile of common uropathogens 
isolated from urine specimens submitted to the diagnostic 
microbiology laboratory at a tertiary teaching hospital and 
assess their antimicrobial susceptibility patterns to commonly 
used antimicrobial agents.
Methods. We conducted a retrospective analysis of laboratory 
reports for all urine specimens submitted for investigations 
over a 1-year period. Isolates were tested by means of the 
Kirby-Bauer disc diffusion method for susceptibility to 
amoxicillin, ciprofloxacin, gentamicin, co-trimoxazole and 
nitrofurantoin, and for extended-spectrum beta-lactamase 
(ESBL) production.
Results. Out of the total specimens (N=2 203) received over 
the 1-year study period, 51.1% (1 126) of the urine samples 
were culture-positive, the majority (65.4%) having come 
from females. The most common isolate was Escherichia coli 
(39.0%) followed by Klebsiella species (20.8%) and Enterococcus 
faecalis (8.2%). The Gram-negative isolates displayed a very 
high level of resistance to amoxicillin (range 43 - 100%) 
and co-trimoxazole (range 29 - 90%), whereas resistance to 
gentamicin (range 0 - 50%) and ciprofloxacin (range 0 - 33%) 
was lower. E. coli isolates were susceptible to nitrofurantoin 
(94%), and ESBL production was significantly higher (p=0.01) 
in the hospital isolates, compared with those from the 
community referral sites.
Conclusions. The culture-positive rate for uropathogens was 
high, with a greater incidence among females. E. coli was the 
most common aetiological agent identified, and remained 
susceptible to nitrofurantoin. Resistance levels to amoxicillin 
and co-trimoxazole were very high for all Gram-negative 
isolates, and it is recommended that these antibiotics should 
not be used for the empiric treatment of urinary tract 
infections.
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and antimicrobial susceptibility testing. Culture is done 
using a calibrated loop; 0.001 ml of urine is inoculated on 5% 
sheep blood agar and MacConkey agar plates. The presence 
of at least 105 colony-forming units (CFU) per ml of urine is 
considered as significant bacteriuria. The colonies are identified 
by means of standard biochemical tests. Susceptibility testing is 
done using the Kirby-Bauer disc diffusion method. McFarland 
0.5 standardised suspension of bacteria (1.5×108 CFU/ml) is 
prepared and swabbed over the surface of a Mueller-Hinton 
agar plate. Paper discs containing single-concentration 
antimicrobial agent are placed onto the surface; these plates 
are then incubated at 35°C for 18 - 24 hours. Diameters and 
inhibition zones produced by the antimicrobial substance are 
measured, and a millimetre reading for each antimicrobial 
agent is compared with that specified in the interpretive tables 
provided in the Clinical and Laboratory Standards Institute 
(CLSI) documents.5
Isolates were tested for susceptibility to the following 
antibiotics: amoxicillin, ciprofloxacin, gentamicin, co-
trimoxazole and nitrofurantoin, and for extended-spectrum 
beta-lactamase (ESBL) production.
Results
Uropathogens from DGM and the referral sites are listed in 
Table I. A positive culture for uropathogens was found in  
1 125 (51.1%) of the 2 203 urine samples submitted for culture. 
Among the 1 125 culture-positive samples, a total of 1 235 
isolates was obtained; of the samples, 1 015 (90.2%) had a 
single organism cultured, and 110 (9.8%) had more than one 
isolate.
The mean age of patients with culture-positive specimens 
was 35.2 years (SD 21.1 years); 736 (65.4%) were female, 360 
(32%) male, and gender was not specified in 29 (2.6%).
The most common isolate at DGM was E. coli (38%), 
followed by Klebsiella species (22%), Enterococcus faecalis 
(8%) and Proteus species (7%). The trend was similar at the 
referral sites, the most common being E. coli (42%), followed 
by Klebsiella species (15%), E. faecalis (11%), and Enterobacter 
species (5%) (Figs 1 and 2).
Most of the common Gram-negative isolates displayed a 
very high level of resistance to amoxicillin (range 43 - 100%) 
and co-trimoxazole (range 29 - 90%) for isolates from both 
Table I. Distribution of isolated uropathogens from Dr George Mukhari Hospital and referring sites
         DGM   Non-DGM
      N (%)   N (%)   N (%)
Total No. of specimens    2 203 (100)  1 887/2 203 (85.7)  316/2 203 (14.3)
Total No. of specimens with uropathogens  1 125/2 203 (51.1)  953/1 887 (50.5)  172/316 (54)
Total isolates     1 235 (100)  1 040/1 235 (84.2)  195/1 235 (15.8)
1 organism isolated    1 015/1 235 (82.2)  866/1 040 (83.3)  149/195 (76.4)
2 organisms isolated    220/125 (17.8)  174/1 040 (16.7)  46/195 (23.6)
Total Gram-negatives    974/1 235 (78.9)  824/1 040 (79.2)  150/195 (76.9)
Isolates
Escherichia coli     482/1 235 (39.0)  398/1 040 (38.3)  84/195 (43.1)
Klebsiella pneumoniae    209/1 235 (16.9)  188/1 040 (18.1)  21/195 (10.8)
Klebsiella oxytoca    30/1 235 (2.4)  21/1 040 (2.0)  9/195 (4.6)
Klebsiella ozaenae    19/1 235 (1.5)  19/1 040 (1.8)  0/195 (0)
Proteus mirabilis    69/1 235 (5.6)  65/1 040 (6.3)  4/195 (2.1)
Proteus vulgaris     16/1 235 (1.3)  12/1 040 (1.2)  4/195 (2.1)
Enterobacter spp.    47/1 235 (3.8)  37/1 040 (3.6)  10/195 (5.1)
Pseudomonas spp.    40/1 235 (3.2)  36/1 040 (3.5)  4/195 (2.1)
Acinetobacter spp.    26/1 235 (2.1)  22/1 040 (2.1)  4/195 (2.1)
Citrobacter spp.     24/1 235 (1.9)  17/1 040 (1.6)  7/195 (3.6)
Others     12/1 235 (1.0)  9/1 040 (0.9)  3/195 (1.5)
Total Gram-positives    186/1 235 (15.1)  152/1 040 (14.6)  34/195 (17.4)
Isolates
Enterococcus faecalis    101/1 235 (8.2)  80/1 040 (7.7)  21/195 (10.8)
Group B streptococci    29/1 235 (2.3)  26/1 040 (2.5)  3/195 (1.5)
Staphylococcus spp.*    26/1 235 (2.1)  23/1 040 (2.2)  3/195 (1.5)
Other Streptococus spp.†    22/1 235 (1.8)  16/1 040 (1.5)  6/195 (3.1)
Staphylcoccus saprophyticus   4/1 235 (0.3)  3/1 040 (0.3)  1/195 (0.5)
Others     4/1 235 (0.3)  4/1 040 (0.4)  0/195 (0)
Yeast
Candida albicans     52/1 235 (4.2)  43/1 040 (4.1)  9/195 (4.6)
Candida diversus     14/1 235 (1.1)  13/1 040 (1.3)  1/195 (0.5)
Non-Candida spp.     9/1 235 (0.7)  8/1 040 (0.8)  1/195 (0.5)
*Includes  S. aureus, MRSA.
†Includes streptococcus groups D, F, G. S. pnuemoniae.
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DGM and elsewhere. Resistance to gentamicin (range 0 - 
50%) was lower, with similar results from the referral sites. 
Resistance to ciprofloxacin (range 0 - 33%) was also lower, with 
similar results from the referral sites (most notably to Proteus 
spp., which did not show any resistance (0%)) (Table II).
E. coli resistance to nitrofurantoin (6%) was very low; 
however, resistance to K. pneumoniae and P. mirabilis was high: 
44% and 82% respectively (49 out of 60 isolates) for DGM. 
ESBL production was significantly higher (p=0.01) among 
DGM isolates than in those from the referral sites.
E. coli was highly resistant to amoxicillin and co-trimoxazole 
at DGM, with similar results for the referral sites; however, it 
remains susceptible to nitrofurantoin with no variation at the 
referral sites. ESBL production was significantly lower (p=0.01) 
among the non-DGM isolates (Fig. 3).
Discussion
E. coli (39.0%) was the most common uropathogen isolated 
at DGM and the referral sites, followed by Klebsiella species 
(20.8%) and E. faecalis (8.2%). This finding is in keeping with 
studies from other developing countries,1,4,6-9 where E. coli was 
the predominant uropathogen, followed by K. pneumoniae. 
The distribution of the uropathogens at DGM was similar to 
that at the referral sites. The culture-positive rate (51%) for 
uropathogens was higher than found in Nicaragua9 and India,10 
Fig. 1. The percentage distribution of uropathogens from Dr George Mukhari Hospital.

Fig. 1. The percentage distribution of uropathogens from Dr George 
Mukhari Hospital.
Fig. 2. The percentage distribution of uropathogens from the referral sites.

Fig. 2. The percentage distribution of uropathogens from the referral sites.
Fig. 3. Percentage resistance of E. coli to various antimicrobials at DGM 



















Table II. Antimicrobial susceptibilities among common Gram-negative uropathogens from DGM and non-DGM
Pathogen            Site        Amoxi r (%)          Cipro r (%)           Genta r (%)            Cotri r (%)            Nitro r (%)            ESBL production (%)
Escherichia          DGM     327/387 (84.5)       63/366 (17.2)    49/370 (13.2) 265/359 (73.8)       21/372 (5.6)           42/354 (11.9)
coli            Non-      72/90 (80)       10/87 (11.5)    8/90 (8.9) 59/85 (69.4)           5/88 (5.7)            2/77 (2.6)
            DGM
Klebsiella             DGM     190/193 (98.4)       58/182 (31.9)    94/189 (49.7) 115/177 (65)          81/183 (44.3)         76/187 (40.6)
pneumoniae          Non-      18/19 (94.7)       2/17 (11.8)    6/17 (35.3) 8/16  (50)               5/16 (31.3)            5/16 (31.3)
            DGM
Klebsiella             DGM     17/18 (94.4)       5/18 (27.8)    6/17 (35.3) 12/17 (70.6)           2/18 (11.1)            3/14 (21.4)
oxytoca            Non-      9/9 (100)       3/9 (33.3)    2/9 (22.2) 5/9 (55.6)               1/9 (11.1)            1/7 (14.3)
            DGM
Proteus                DGM     28/58 (48.3)       0/58 (0)    8/59 (13.6) 27/53 (50.9)           49/60 (81.7)          4/54 (7.4)
mirabilis            Non-      3/7 (42.9)       0/7 (0)    0/7 (0)   2/7 (28.6)               6/7 (85.7)            0/7 (0)
            DGM
Proteus            DGM     10/11 (90.9)       0/11 (0)    3/11 (27.3) 9/10 (90)                8/10 (80)            1/10 (10)
vulgaris            Non-      3/4 (75)       0/4 (0)    0/4 (0)  2/4 (50)               1/4 (25)            0/3 (0)
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with culture rates of 30% and 39% respectively. For the culture-
positive specimens, 65% were from females and 32% from 
males, which is a finding similar to those reported from India10 
(63% females and 37% males) and Palestine11 (75% females and 
25% males). These findings are to be expected as women are 
more prone to UTIs than men.
The common Gram-negative isolates had a very high-level 
resistance to amoxicillin and co-trimoxazole, as in reports from 
the Central African Republic6 and India4,10 and from a previous 
local study on urinary E. coli.12 This high level of resistance may 
be attributed to the frequent use of these antibiotics for therapy 
and prophylaxis. Although these common Gram-negative 
bacteria displayed much lower resistance to ciprofloxacin and 
gentamicin compared with other antimicrobial agents, the 
levels of resistance were higher than found in studies from the 
Central African Republic,6 Kuwait,2 and even than the urinary 
E. coli isolates finding in the previous local study.12
E. coli isolates are susceptible to nitrofurantoin at DGM 
and the referral sites. However, K. pneumoniae and P. mirabilis 
are less susceptible to nitrofurantoin; similar findings were 
reported in several other countries.1,2,7,13,14 ESBL production was 
significantly higher (p=0.01) in DGM than non-DGM isolates, 
reflecting greater use of broad-spectrum antibiotics for the 
hospitalised patient population.
Conclusion
In our study, the culture-positive rate for uropathogens was 
high, with the majority coming from female patients. As 
expected, E. coli was the most common aetiological agent 
identified, and remains susceptible to nitrofurantoin. It would 
therefore be the ideal antibiotic to use for uncomplicated lower 
UTIs. Resistance levels to amoxicillin and co-trimoxazole are 
extremely high, and we recommend that these antibiotics 
should not be used for the empiric treatment of UTIs. However, 
it was beyond the scope of this study to determine whether 
co-amoxiclav instead would be a suitable antibiotic. Although 
most of the isolates remain sensitive to ciprofloxacin, of interest 
is its use in managing multidrug-resistant tuberculosis in South 
Africa. A policy decision must be made on whether this drug 
should be restricted from use in other conditions such as UTI 
so that it may be used more specifically – if not exclusively – in 
tuberculosis.
Our study provides useful information for the proper 
treatment of UTIs and discourages the indiscriminate use 
of antibiotics, so helping to prevent further development of 
drug-resistant bacteria – a major public health problem in both 
hospital- and community-acquired UTIs. We therefore suggest 
a continual audit of antimicrobial susceptibility patterns among 
uropathogens as a cause of morbidity, especially in children, 
for the purpose of gathering more data.
We thank the DGM laboratory personnel for their assistance in the 
collection of specimens.
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